Mission to ZERO Aims to Reset National Benchmark

Magnolia launches nationwide initiative to raise awareness of patient safety risks caused by false-positive diagnostic results for sepsis. The goal is to drive change by reducing the national blood culture contamination benchmark, while partnering with hospitals in their mission to eliminate blood culture contamination and false positive CLABSI reporting.
Learn More

Newsweek Selects Steripath as a 2020 Best Product in Infection Prevention

The Best Health Care series by Newsweek and The Leapfrog Group highlights the nation's most promising products and technologies to help patients and healthcare workers avoid infection.
Read Article

Introducing Steripath Gen2 with Integrated Syringe

The trusted solution for reducing blood culture contamination is now optimized for ‘hard stick’ patients and syringe collection protocols as the only diversion device with a preassembled, integrated syringe configuration.
Learn About Steripath

Steripath Gen2 Products Receive FDA 510K Clearance with Exclusive Indication

The Steripath Gen2 product family are now the only FDA cleared devices indicated to reduce blood culture contamination when contaminants are present, compared to standard method controls without diversion.
Learn About Steripath

Featured Videos

Latest News

More
    News

    Magnolia Medical Launches New “Diverted” Multi-Media Advertising Campaign to Educate Healthcare Providers on Benefits of Steripath® 

    April 14, 2021
    Seattle, WA – April 14, 2021 – Magnolia Medical Technologies, Inc. recently launched a new multi-media advertising campaign to promote the benefits of the Steripath® Initial Specimen Diversion Device® (ISDD®) platform.   Built around the theme “Diverted”, the campaign underscores the critical need for the use of Magnolia’s ISDD, which diverts the initial 1.5-2.0…
    Read More

    SHEA 2021

    April 13, 2021

    Society for Pediatric Nurses 2021

    April 13, 2021

    Webinar: Meeting a New Blood Culture Contamination Benchmark

    April 13, 2021

    World Microbe Forum 2021

    April 13, 2021

    APIC 2021

    April 13, 2021

    Learn More About Steripath

    The Problem with False Positives

    False-positive blood culture results can have meaningful downstream consequences. Learn about the impact.

    Read More >
    The Benefits of Steripath

    See how you can benefit from reducing blood culture contamination at your hospital.

    Read More >
    Backed by Evidence

    Discover Steripath's independent clinical study results for yourself.

    Read More >
    About Us

    Discover Magnolia Medical's company history and current leadership

    Read More >
    Careers

    Think you have what it takes to join Team Magnolia?

    See Openings
    Patents

    Explore our vast portfolio of industry-leading, medical device innovation

    Read More >